Kinapse

At Kinapse, a Syneos Health™ company, we are life sciences specialists, offering consulting, capability building and operational services.

[Kinapse @kinapseglobal]

Join us for our webinar and learn more about the value that dedicated #qualitycontrol brings to #medicalwriting documents.
Friday May 21st
9am EST | 2pm BST | 6:30pm IST

Follow the link and register to join this free #webinar https://t.co/dHgNz2bLmf

[Kinapse @kinapseglobal]

Pharmacovigilance is evolving, follow the link below to see how we’ve assessed the strategy of #PRAC and the #MHRA in our free overview document https://t.co/fhC43He47v

#pharmacovigilance #Pharmaceuticals #drugsafety #kinapse

[Kinapse @kinapseglobal]

The #MHRA have released guidance on how UK only licences will operate moving forward, do you know what you need to do and by when?
Follow the link below for more information on how Kinapse can help you market your products in a post #BrexitUK. https://t.co/qy0W8dWA1f
#Brexit

[Kinapse @kinapseglobal]

Kinapse has launched #Standalone #Document #QC services as one of its core services. This approach improves the quality of all #regulatory documentation, reduces timelines for document creation and avoids regulatory delays caused by poor quality documents.https://t.co/x96dRf32sg

[Kinapse @kinapseglobal]

Don’t forget to check our blog and get more updates about the ICH Q12 guideline.

https://t.co/en6UsqtBxO

#ICH #Q12 #regulatoryrequirements #kinapse

[Kinapse @kinapseglobal]

In Aug 2019 a major change concerning the implementation of the new model for #APIs regulation in Brazil has been proposed by Brazilian Health #Regulatory Agency (#ANVISA).
Read the summary below and learn more about the change. https://t.co/kh4OntDRAA

#pharmaceutical #ICH

[Kinapse @kinapseglobal]

The deadline to respond to #EMA Art. 5(3) Referral on #NITROSAMINES is fast approaching. Kinapse commits to supporting Marketing Authorisation Holders (MAHs) regarding Nitrosamine Impurities. Learn more here: https://t.co/MQAozpt0qi

#regulatory #marketing #authorization #holders

[Kinapse @kinapseglobal]

Do #ancillary document requests give you a headache? Your opinion matters to us!

#Kinapse really looks forward to understanding your needs and supporting your projects. Please take a minute to fill out Kinapse's #survey
https://t.co/3IOhbrg3fB

#regulatory #pharmaceuticals

[Kinapse @kinapseglobal]

Kinapse provides competitive #Chemistry, #Manufacturing and #Control capabilities and our experts look forward to sharing their insights and experience with you.
Are you interested in learning more? Contact us at [email protected]

#kinapse #regulatory #pharmaceuticals

[Kinapse @kinapseglobal]

Kinapse, a Syneos Health company attends #CBIConference, (January 22-24, Coral Gables, Florida).
Join Kinapse's speakers and do not lose the opportunity to engage in a conversation with them. https://t.co/J66UR5UVhU

[Kinapse @kinapseglobal]

Do ancillary document requests give you a headache?

Follow the link to complete Kinapse's #survey and help us understand your needs.

https://t.co/3IOhbrg3fB

#regulatory #ancillary #requests

[Kinapse @kinapseglobal]

Kinapse, a Syneos Health company will attend CBI #Conference, #ClinicalData #Disclosure, #Transparency & #PlainLanguage Summaries on January 22-24, Coral Gables, Florida. https://t.co/J66UR5UVhU
Join Shalini Dwivedi at Session 7 and learn more about #HealthCanada PRCI.

[Kinapse @kinapseglobal]

Kinapse welcomes the New Year by introducing its #Regulatory capabilities.
Do not hesitate to contact us and engage the conversation about your regulatory projects.
[email protected]

#regulatorycompliance #strategy #clinical #regulatoryrequirements

[Kinapse @kinapseglobal]

On 4th Dec, ICH published final Q12 #guideline and its Annexes. Kinapse have the expertise to support and guide you in 2020!
#pharma #ich #regulatoryrequirements

Check our blog to learn more: https://t.co/AmAuzY2Fxu

[Kinapse @kinapseglobal]

Learn more about Kinapse!

Our #mission

[Kinapse @kinapseglobal]

Reminder: Reserve now your place at our today’s #Webinar and learn more about how to write high-quality Plain Language summaries. 
December 06
9 am EST | 2pm GMT | 3pm CET |
Follow the link and register today: https://t.co/ByeqpZ2BDt

#clinicaltrials #plainlanguage

[Kinapse @kinapseglobal]

Kinapse wishes Happy #Thanksgiving to all of our US colleagues, friends and their families!

[Kinapse @kinapseglobal]

Kinapse, a Syneos Health company will attend DIA CTD & Clinical Transparency conference, on December 04-05, 2019, in Amsterdam.
Do not hesitate to meet our colleagues and engage the conversation about your project and disclosure requirements.
#syneoshealth #transparency

[Kinapse @kinapseglobal]

Kinapse would like to congratulate all the winners at the TOPRA awards last night celebrating regulatory achievement. We were pleased to be part of the celebrations with the Syneos Health global regulatory consulting team.

#syneoshealth #kinapse #TOPRA #Regulatory

[Kinapse @kinapseglobal]

Kinapse launches https://t.co/bwV3yiTlUj, a web portal for sponsors to publicly share plain language summaries of clinical trials. With the launch of this web portal, Kinapse is now able to provide end-to-end writing through dissemination services for PLS. https://t.co/ufty9QQknZ